Figure 4
From: Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM
MiR-106 inhibits glioma cell proliferation in vitro. (A) In silico analysis of SLC2A3 mRNA expression and the correlation to proliferation-related mRNAs. Heatmap of gene expression of proliferation-related genes in patients was sorted by level of SLC2A3 expression (columns). (B) MTT assay displayed that cells treated with miR-106a proliferated at a significantly lower rate than control groups after transfection. (C) After 48Â h treatment, cells were harvested and performed by cell cycle assay. Data were presented as the mean of triplicate experiments.